Psychiatry · Lexington, KY
NPI
1154448991
Since 2007
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1062 Wellington Way
Lexington, KY, 40513
Phone (859) 219-9399
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$513K
2,263 prescriptions
Company payments, 2025
$161K
From 18 companies
Medicare prescription drug claims, 2024
In 2024, the drug Mark S Wright prescribed most often to Medicare patients was Bupropion Xl (Bupropion Hcl), with 247 prescriptions and refills. In total Mark S Wright wrote 2,263 Medicare prescriptions that cost $513K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Bupropion Xl Bupropion Hcl | 247 | 586 | 59 | $6,421 |
| Alprazolam Generic | 203 | 203 | 43 | $418 |
| Duloxetine Hcl Generic | 188 | 440 | 44 | $5,149 |
| Clonazepam Generic | 149 | 157 | 26 | $502 |
| Buspirone Hcl Generic | 146 | 363 | 47 | $3,711 |
| Lamotrigine Generic | 97 | 249 | 25 | $1,590 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 95 | 189 | 24 | $6,132 |
| Trazodone Hcl Generic | 74 | 158 | 24 | $1,245 |
| Fluoxetine Hcl Generic | 71 | 179 | 20 | $470 |
| Olanzapine Generic | 55 | 107 | 11 | $4,140 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 54 | 100 | 15 | $2,281 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 51 | 127 | 12 | $825 |
| Lorazepam Generic | 45 | 45 | Under 11 | $142 |
| Quetiapine Fumarate Generic | 44 | 86 | 13 | $645 |
| Sertraline Hcl Generic | 38 | 98 | Under 11 | $658 |
Brand drugs: 156 claims; generic drugs: 2,107 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark S Wright $161K ($161K in general payments such as food, travel and fees) from 18 companies. The largest payer was Axsome Therapeutics, Inc. with $67K.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 64 | $67K |
| Neurocrine BioSciences, Inc. NBIX | 23 | $29K |
| Supernus Pharmaceuticals, Inc. SUPN | 38 | $22K |
| Alkermes, Inc. ALKS | 17 | $17K |
| Teva Pharmaceuticals USA, Inc. TEVA | 9 | $14K |
| Tris Pharma Inc | 14 | $8,316 |
| Noven Therapeutics, LLC | 10 | $2,632 |
| Corium, LLC | 8 | $146 |
| Collegium Pharmaceutical, Inc. COLL | 6 | $118 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $93.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.